Our firm advised a professional association of manufacturers of pharmaceutical products in the context of the adoption of Regulation 726/2004 establishing community procedures for the authorization and monitoring of medicinal products for human and veterinary use as well as the 2001 directive. / 83 establishing a community code relating to medicinal products for human use.
We managed to get an amendment, which we drafted on behalf of the client, to pass through the European Parliament and the Council of the European Union. Thanks to this amendment, our client has obtained that his product falls into the category of products requiring less restrictive labeling than other products.
Example of a pharmaceutical project
